Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Urea SCHEMBL5011099 | 0.93 | LMNA (0.36) | LMNAALOX15HSD17B10EPHX1 | |
| Acetamide SCHEMBL15514561 | 0.91 | LMNA (0.38) | LMNAALOX15HSD17B10EPHX1 | |
| SCHEMBL27605444 | 0.86 | LMNA (0.35) | LMNA | |
| Butyramide SCHEMBL29189062 | 0.85 | ALDH1A1 (0.34) | LMNAALOX15HSD17B10FFAR3HDAC3 | |
| Guanidine SCHEMBL8997432 | 0.83 | LMNA (0.36) | LMNA | |
| SCHEMBL28130876 | 0.83 | LMNA (0.36) | LMNAHSD17B10EPHX1 | |
| Acrylamide SCHEMBL16052936 | 0.83 | TSHR (0.44) | LMNA | |
| SCHEMBL6660409 | 0.83 | TDP1 (0.48) | LMNA | |
| Acetic Acid SCHEMBL28618083 | 0.82 | LMNA (0.33) | LMNAFFAR3EPHX1 | |
| Methylamine SCHEMBL110166 | 0.82 | LMNA (0.41) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108368268-B | Titanium complexes as sulfidation catalysts | 汉高股份有限及两合公司 | 2021-03-19 | — | — | CN | disclosed |